Work

Multicentre trial of telemonitored circadian rhythms and electronic patient-reported outcomes (ePROs) for improving tolerability of initial mFOLFIRINOX cycles in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC): MultiDom (NCT04263948).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4204

Authors: Francis Albert Lévi, Claudia Viaro, Ayhan Ulusakarya, Sandrine Dulong, Dounya Boudriche, Rachel Bossevot, Elise Colle, Imène Hadj-Naceur, Xiaomei Li, Tambo Bathily, Anne Thirot Bidault, Pascal Agranat, Kristian Romano, Barbel Finkenstadt-Rand, Rene Adam, Mohamed Bouchahda, Pascal Hammel

Institutions: Université Paris-Saclay, Hôpital Paul-Brousse, Chronothérapie, cancers et transplantation, Assistance Publique – Hôpitaux de Paris, University of Warwick, Inserm, Fondation Ramsay Santé

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162562483

Cites:

Cited by:

Related to: